MPH Health Care AG
MPH Mittelständische Pharma Holding AG: Positive business performance in the first 9 months of 2015
DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): 9-month figures/Quarter Results MPH Mittelständische Pharma Holding AG: In the first 9 months of 2015 MPH Group achieved sales to the amount of 178.6 million Euro (previous year’s period: 163.8 million Euro). The profit for the period totalled 4.0 million Euro. The affiliated companies of MPH AG could further expand their position in the healthcare market. The performance of the shareholdings was very positive. The listed investments in HAEMATO, M1 and CR Capital valued at 133.5 million Euro as of 30.09.2015. Compared to the previous quarter the entire intrinsic value of the MPH AG increased by 16 % and totalled 134.6 million Euro as of 30.09.2015. This corresponds to 3.14 Euro per share. We are very pleased with the performance of our investments. About MPH Mittelständische Pharma Holding AG: The MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) on the Frankfurt stock exchange. Key figures for the share of MPH Mittelständische Pharma Holding AG: Contact: Frau Linda Reichelt Phone: +49 (0) 30 897308660 Fax: +49 (0) 30 897308669
2015-11-30 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English | |
Company: | MPH Mittelständische Pharma Holding AG | |
Grünauer Straße 5 | ||
12557 Berlin | ||
Germany | ||
Phone: | 030 / 897 308 660 | |
Fax: | 030 / 897 308 669 | |
E-mail: | info@mph-ag.de | |
Internet: | www.mph-ag.de | |
ISIN: | DE000A0L1H32 | |
WKN: | A0L1H3 | |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt | |
End of News | DGAP News Service |